BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9434469)

  • 1. [Aldose reductase inhibitor SNK-860].
    Hibi C
    Nihon Rinsho; 1997 Nov; 55 Suppl():212-5. PubMed ID: 9434469
    [No Abstract]   [Full Text] [Related]  

  • 2. Fidarestat. Sanwa Kagaku/NC Curex/Sankyo.
    Giannoukakis N
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1233-9. PubMed ID: 14649216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fidarestat (SNK-860)].
    Hibi C
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():594-600. PubMed ID: 12387056
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
    Hotta N; Sakamoto N
    Nihon Rinsho; 1987 Dec; 45(12):3010-27. PubMed ID: 3128677
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].
    Christensen JE; Larsen AB; Gregersen G
    Ugeskr Laeger; 1987 Nov; 149(46):3111-4. PubMed ID: 3127975
    [No Abstract]   [Full Text] [Related]  

  • 6. Aldose reductase inhibition for diabetic neuropathy.
    Lancet; 1983 Oct; 2(8356):969. PubMed ID: 6138528
    [No Abstract]   [Full Text] [Related]  

  • 7. Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review.
    Schemmel KE; Padiyara RS; D'Souza JJ
    J Diabetes Complications; 2010; 24(5):354-60. PubMed ID: 19748287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug evaluation: ranirestat--an aldose reductase inhibitor for the potential treatment of diabetic complications.
    Giannoukakis N
    Curr Opin Investig Drugs; 2006 Oct; 7(10):916-23. PubMed ID: 17086937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy.
    Hara T; Nakamura J; Koh N; Sakakibara F; Hamada Y; Sasaki H; Naruse K; Nakashima E; Takeuchi N; Inukai S
    J Lab Clin Med; 1995 Dec; 126(6):541-7. PubMed ID: 7490513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aldose reductase inhibitors on the progression of nerve damage.
    Greene DA; Sima AA
    Diabet Med; 1993; 10 Suppl 2():31S-32S. PubMed ID: 8334837
    [No Abstract]   [Full Text] [Related]  

  • 11. Aldose reductase inhibitors: the end of an era or the need for different trial designs?
    Pfeifer MA; Schumer MP; Gelber DA
    Diabetes; 1997 Sep; 46 Suppl 2():S82-9. PubMed ID: 9285505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of myo-inositol and sorbinil studies.
    Clements RS
    Clin Physiol; 1985; 5 Suppl 5():90-3. PubMed ID: 3938689
    [No Abstract]   [Full Text] [Related]  

  • 13. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.
    Sima AA; Bril V; Nathaniel V; McEwen TA; Brown MB; Lattimer SA; Greene DA
    N Engl J Med; 1988 Sep; 319(9):548-55. PubMed ID: 3136331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent clinical experience with aldose reductase inhibitors.
    Krans HM
    Diabet Med; 1993; 10 Suppl 2():44S-48S. PubMed ID: 8334842
    [No Abstract]   [Full Text] [Related]  

  • 16. Aldose reductase inhibitors.
    Oka M; Kato N
    J Enzyme Inhib; 2001 Dec; 16(6):465-73. PubMed ID: 12164386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites.
    El-Kabbani O; Wilson DK; Petrash M; Quiocho FA
    Mol Vis; 1998 Sep; 4():19. PubMed ID: 9756955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can aldose reductase inhibition ameliorate diabetic neuropathy?
    González ER
    JAMA; 1981 Sep; 246(11):1169-70. PubMed ID: 6790734
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibitory effect of 7 agents on bovine testis aldose reductase].
    Liu C; Zhu X
    Zhongguo Zhong Yao Za Zhi; 1997 Jun; 22(6):372-3, inside back cover. PubMed ID: 11038893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldose reductase inhibition in the treatment of diabetic neuropathy: where are we in 2004?
    Gabbay KH
    Curr Diab Rep; 2004 Dec; 4(6):405-8. PubMed ID: 15539002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.